Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing Revision: v3.6.4. This reflects a software version update rather than changes to study data or page content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new build/version of the study history page.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the study history, replacing the previous 'Revision: v3.6.2'. This reflects an updated platform release recorded in the version history.SummaryDifference0.0%

- Check60 days agoChange DetectedA new history entry was added for 2026-06-26 indicating a Study Status update with version 142 and Revision: v3.6.2, and an earlier 2026-02-20 entry as well as Revision: v3.6.0 were removed.SummaryDifference0.1%

- Check74 days agoChange DetectedThe record now shows that the study is not enrolling participants, and the history includes a new revision (v3.6.0) replacing the prior revision (v3.5.5).SummaryDifference0.1%

- Check81 days agoChange DetectedThe history now includes a new latest revision tag v3.5.5, while the previous revision v3.5.4 is removed from the list.SummaryDifference0.0%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.